Home » Newsletters » BioWorld Science

BioWorld Science

July 22, 2011

View Archived Issues

Merck KGaA presents novel PDK1 inhibitors with potential to treat cancer

Innovative oral MS therapy advances to phase IIa

Summit identifies new approach to treat Alzheimer's disease

Clinical studies evaluate lersivirine versus efavirenz in HIV and its effect on methadone PK

New androgen receptor antagonists reported

S*BIO discloses novel mTOR inhibitors

Novel histamine H4 receptor antagonists prepared by Palau Pharma

Pfizer divulges new MPGES-1 inhibitors for pain

Japanese company patents new angiotensin AT receptor antagonists/PPAR-gamma agonists

D-Pharm clear to continue phase III DP-b99 study

Phase II Aimspro trial for bladder dysfunction in MS advances

Aeterna Zentaris reports nonclinical milestone for oral prostate cancer vaccine

Millennium files sNDA to add survival data to Velcade MM label in U.S.

Pfizer's new opioid NOP receptor antagonists show preclinical potential to treat AD

Potent serotonin 5-HT4 receptor agonist described by Suven

NanoCarrier and Orient Europharma commence phase II study of Nanoplatin

Cellceutix cleared to conduct phase I trial of anticancer drug

Regulus Therapeutics and GSK alliance identifies third microRNA target

EMA accepts Santhera Pharmaceuticals' idebenone MAA for review

First-in-human trial assesses effects of GSK-1034702 on cognitive function

Merck & Co. and Simcere sign agreement to establish joint venture in China

FDA issues safety warning regarding use of Multaq in patients with permanent AF

Bristol-Myers Squibb to acquire Amira Pharmaceuticals

Manhattan Pharmaceuticals and FDA reach agreement on SPA for phase III AST-726 trial

Apricus files MAA in Switzerland for Vitaros

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...